Pfizer is spending more than $7 billion to buy biotech Metsera to try to catch cup in the obesity drug market.
The charts on this telehealth stock point to strong gains ahead, according to Katie Stockton
Katie Stockton breaks down the technical outlook on this telehealth name.
Bad Bunny concerts boost Puerto Rico GDP by $400 million, estimates Wells Fargo, boosting this stock
Puerto Rico’s local economy got a massive boost from Bad Bunny’s Bad Bunny’s 31-date residency, giving Popular a lift as well, according to Wells Fargo.
Trump’s $100,000 visa plan could hit these companies the hardest
Baird looked at consulting and professional services firms with the highest average number of H-1B visa approvals.
Best Stocks: A look at our energy stocks, including an A+ name
Josh Brown and Sean Russo take a look at the energy sector, including a best-in-class name that’s on their Best Stocks list.
Traders believe one economic number is the most important this week – plus a tech name with big upside
The conventional wisdom is to watch the core PCE inflation report Friday, but Jay Woods believes the jobless claims report is the more important one for markets.
Nvidia, Macy’s see big sales by execs as market soars to record highs
The stock market scaled to record levels recently, leading some executives at major corporations to cash in.
A ‘short strangle’ options trade for a stock trapped in a trading range
Michael Khouw goes through the basics of a strangle options trade and how this software stock could be a good candidate for one.
Eric Jackson, who led Opendoor meme rip, has a new pick he calls the ‘Shopify of mortgages’
The EMJ Capital founder called Better Home “the Shopify of mortgages” and said the company is rebuilding a $15 trillion industry from scratch with AI.
Piper Sandler raises Tesla price target to $500, says it can fight off China competitors with AI lead
Piper Sandler raised its price target for Tesla to $500 from $400, citing the EV maker’s lead in AI as a catalyst for its growth.